1Y Close · As of Aug 26, 2026
JW SHINYAK operates in the Pharmaceuticals sector.
Legal name: JW SHINYAK CORPORATION
In fiscal year 2025, JW SHINYAK (067290) reported revenue of 81.0 billion KRW, down 12.9% from 93.0 billion KRW a year earlier.
Operating profit was 7.5 billion KRW and net income was 15.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 111.7 billion KRW, with a P/B of 2.74.
These figures can be verified in the DART filing (receipt no. 20260318001271).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 81.0B | 7.5B | 15.7B |
| 2024 | 93.0B | 10.0B | 5.1B |
| 2023 | 104.2B | 5.6B | -37.4B |
Recent Filings
Semi-Annual Report (2026.06)
Operating (Preliminary) Earnings (Fair Disclosure)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-12 | Operating (Preliminary) Earnings (Fair Disclosure) |